Nicotine induces chromatin changes and c-Jun up-regulation in HL-60 leukemia cells

Oncol Rep. 2005 Dec;14(6):1553-8.

Abstract

Although nicotine has been implicated as a potential factor in the pathogenesis of human cancer, its mechanisms of action regarding cancer development remain largely unknown. HL-60 cells were used to investigate the effects of a short-term treatment with nicotine at concentrations found in the blood of smokers. The findings show that nicotine induces chromatin decondensation, histone H3 acetylation and up-regulation of the c-Jun transcription factor mRNA. This increase is inhibited by mecamylamine, a nicotinic receptor antagonist, suggesting that nicotine alters cellular function directly via nicotinic acetylcholine receptors and may then play a role in cell physiology and tumor promotion.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylation / drug effects
  • Cell Nucleus / drug effects
  • Cell Nucleus / genetics
  • Cell Nucleus / metabolism
  • Chromatin / drug effects*
  • Chromatin / metabolism
  • Dose-Response Relationship, Drug
  • Gene Expression / drug effects
  • HL-60 Cells
  • Histones / metabolism
  • Humans
  • Immunoblotting
  • Leukemia, Promyelocytic, Acute / genetics
  • Leukemia, Promyelocytic, Acute / metabolism
  • Leukemia, Promyelocytic, Acute / pathology
  • Mecamylamine / pharmacology
  • Nicotine / pharmacology*
  • Nicotinic Antagonists / pharmacology
  • Proto-Oncogene Proteins c-fos / genetics
  • Proto-Oncogene Proteins c-jun / genetics*
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Reverse Transcriptase Polymerase Chain Reaction
  • Time Factors
  • Up-Regulation / drug effects
  • Up-Regulation / genetics

Substances

  • Chromatin
  • Histones
  • Nicotinic Antagonists
  • Proto-Oncogene Proteins c-fos
  • Proto-Oncogene Proteins c-jun
  • RNA, Messenger
  • Mecamylamine
  • Nicotine